Evaluation of the effectiveness of symptom control in patients with cancer

Not Applicable

• Conditions: Advanced Cancer.; Malignant neoplasm; C00-C97

• Registration Number: IRCT20230408057851N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Having a definite cancer diagnosis with the opinion of an oncologist
Physical and mental ability to communicate and complete questionnaires
Having a score of at least 4 in one of the annoying symptoms such as pain or other physical symptoms
Patient availability during the 2-week study period
First referral to the palliative care service

Exclusion Criteria

The patient is in the final phase of the disease
Prediction of survival of less than one month for the patient

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The intensity score of common symptoms experienced by cancer patients in the Edmonton Symptom Assessment Scale questionnaire. Timepoint: Time intervals for evaluation at the beginning of the study (before the cancer symptom management plan), and by passing 7, and 14 days from the intervention (Follow-up). Method of measurement: Edmonton Symptom Assessment Scale questionnaire (ESAS).;Quality of life in cancer patients. Timepoint: Time intervals for evaluation at the beginning of the study (before the cancer symptom management plan), and by passing 7, and 14 days from the intervention (Follow-up). Method of measurement: The European Organization for Research and Treatment of Cancer core quality of life questionnaire (EORTC-QLQ-C??).